Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
-0.35%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$23.6B
AUM Growth
-$1.36B
(-5.5%)
Cap. Flow
-$604M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
34.03%
Holding
1,274
New
126
Increased
411
Reduced
478
Closed
172
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$163M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$146M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$142M |
| 4 |
Eli Lilly
LLY
|
+$110M |
| 5 |
Salesforce
CRM
|
+$103M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$329M |
| 2 |
Intuitive Surgical
ISRG
|
+$162M |
| 3 |
Accenture
ACN
|
+$127M |
| 4 |
Hershey
HSY
|
+$113M |
| 5 |
Deere & Co
DE
|
+$111M |
Sector Composition
| 1 | Technology | 33.05% |
| 2 | Financials | 13.6% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Healthcare | 10.63% |
| 5 | Industrials | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Fox Factory Holding Corp
FOXF
$1.17B
| $381K | ﹤0.01% |
3,846
+71
| +2% | +$7.04K |
|
902
First Advantage
FA
$2.74B
| $378K | ﹤0.01% |
27,421
-231
| -0.8% | -$3.19K |
|
903
Avidity Biosciences
RNA
$5.97B
| $378K | ﹤0.01% |
+59,257
| New | +$378K |
|
904
Calix
CALX
$4.11B
| $377K | ﹤0.01% |
8,224
+314
| +4% | +$14.4K |
|
905
Forrester Research
FORR
$188M
| $376K | ﹤0.01% |
13,011
-6,890
| -35% | -$199K |
|
|
BHR
906
Braemar Hotels & Resorts
BHR
$199M
| $368K | ﹤0.01% |
132,980
| – | – |
|
907
Murphy USA
MUSA
$7.26B
| $365K | ﹤0.01% |
1,069
-2,402
| -69% | -$821K |
|
|
VRE
908
Veris Residential
VRE
$1.49B
| $363K | ﹤0.01% |
+22,003
| New | +$363K |
|
909
Cohu
COHU
$976M
| $362K | ﹤0.01% |
10,516
-2,230
| -17% | -$76.8K |
|
910
Carter Bankshares
CARE
$450M
| $361K | ﹤0.01% |
28,787
| – | – |
|
|
SMAR
911
DELISTED
Smartsheet Inc.
SMAR
| $360K | ﹤0.01% |
8,896
-61,643
| -87% | -$2.49M |
|
912
Hanover Insurance
THG
$6.37B
| $358K | ﹤0.01% |
3,227
-145
| -4% | -$16.1K |
|
913
Castle Biosciences
CSTL
$665M
| $358K | ﹤0.01% |
+21,185
| New | +$358K |
|
914
Mistras Group
MG
$301M
| $357K | ﹤0.01% |
+65,435
| New | +$357K |
|
915
Intellia Therapeutics
NTLA
$1.23B
| $356K | ﹤0.01% |
11,273
+294
| +3% | +$9.3K |
|
916
i3 Verticals
IIIV
$720M
| $356K | ﹤0.01% |
16,836
| – | – |
|
917
Heron Therapeutics
HRTX
$195M
| $353K | ﹤0.01% |
343,127
+3,653
| +1% | +$3.76K |
|
918
Franklin Electric
FELE
$4.2B
| $353K | ﹤0.01% |
3,958
+105
| +3% | +$9.37K |
|
919
RPM International
RPM
$16.5B
| $353K | ﹤0.01% |
+3,723
| New | +$353K |
|
920
Ingersoll Rand
IR
$31.9B
| $352K | ﹤0.01% |
5,525
-7,847
| -59% | -$500K |
|
921
Dave & Buster's
PLAY
$769M
| $351K | ﹤0.01% |
9,468
-22,310
| -70% | -$827K |
|
922
Stellar Bancorp
STEL
$1.61B
| $349K | ﹤0.01% |
16,358
-486
| -3% | -$10.4K |
|
923
Innospec
IOSP
$2.06B
| $347K | ﹤0.01% |
3,397
-2,571
| -43% | -$263K |
|
924
ACV Auctions
ACVA
$1.8B
| $345K | ﹤0.01% |
22,740
+495
| +2% | +$7.51K |
|
925
Guardant Health
GH
$7.05B
| $343K | ﹤0.01% |
11,575
-4,285
| -27% | -$127K |
|